• Home
  • Genovior Biotech Corporation

Genovior Biotech Corporation

About Genovior Biotech Corporation

Genovior is a dedicated CMO/CDMO, focusing on providing clients excellent, efficient, one stop services and solutions, from clinical trials (IND/NDA) to commercialization.

Our services include:
1. Process Development
2. Formulation Development
3. Analytical Development
4. Small Scale Biologics / Injectable Production
5. Commercial Scale Injectable Production
6. Dedicated Oncology Production (API / Injectables)
7. Regulatory Affairs

Generic/Peptide/Biosimilar projects available for out-licensing<...

Read more Show less
Certifications
More certifications Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • TW
  • 2016
    On CPHI since
  • 1
    Certificates
  • 100 - 249
    Employees
Company types
CMO/CDMO
Primary activities
Contract Manufacturer
View company profile
Contact info
  • 88637580280
  • Website
  • 4F No. 50-8 Keyan RD , Zhunan Township , 35053, Miaoll County , Taiwan, China
Show contact info Hide contact info
Meet us at

CPHI Barcelona 2023

Fira Barcelona Gran Via, Spain
24-26 October 2023
View Exhibitor Profile

Products from Genovior Biotech Corporation (5)

  • GBC Production Plant site Video

    Product GBC Production Plant site Video

    Genovior Biotechnology Corporation facility capabilities & current ongoing production lines
  • CDMO/CMO

    Product CDMO/CMO

    Genovior is a dedicated CMO/CDMO, focusing on providing clients excellent, efficient, one stop services and solutions, from clinical trials (IND/NDA) to commercialization.

    Our services include:

    1. Process Development
    2. Formulation Development
    3. Analytical Development
    ...
  • CDMO/CMO 1

    Product CDMO/CMO 1

    PFS, Lyophilization
  • CDMO/CMO 2

    Product CDMO/CMO 2

    PROTEIN, INJECTABLE
  • CDMO/CMO 3

    Product CDMO/CMO 3

    Biologic, Oncology

Genovior Biotech Corporation Resources (3)

  • Interview by Newsweek, Time to Talk

    News Interview by Newsweek, Time to Talk

    An interview with Dr. Steve J.P. Hsu, President of Genovior Biotech.
    25 Mar 2019
  • Interview by Newsweek, Time to Talk

    Brochure Interview by Newsweek, Time to Talk

    Interviewee：Dr. Steve J. P. Hsu (President of Genovior Biotech)
  • COMPANY PRESENTATION

    Video COMPANY PRESENTATION

    Genovior is a dedicated CMO/CDMO, focusing on providing clients excellent, efficient, one stop services and solutions, from clinical trials (IND/NDA) to commercialization.

    Our services include:
    1. Process Development
    2. Formulation Development
    3. Analytical Development
    4. Small Scale Biologics / Injectable Production
    5. Commercial Scale Injectable Production

    6. Dedicated Oncology Production (API / Injectables)
    7. Regulatory Affairs

    Generic/Peptide/Biosimilar projects available for out-licensing
    Oncology-Azacitidine, Bortezomib, Pemetrexed, Fulvestrant
    Peptide-Glucagon, Teriparatide, Octreotide, Terlipressin
    Biosimilar-Liraglutide, Ranibizumab, Denosumab
    Others-Levetiracetam, Palonosetron, Valproate